Will Crowdfunding Finally Bridge the Valley of Death?
By Catherine Shaffer
Wednesday, October 9, 2013
San Francisco – New platforms for crowdfunding of biotech are cropping up as a potential solution to the eternal funding gap for new companies. Representatives from traditional venture investing and the newer crowdfunding paradigm discussed the problems and potential of bringing more and smaller investors into biotech at the early stages at the BIO Investor Forum in San Francisco.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.